DTIL vs XLI
Precision BioSciences Inc (DTIL) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Precision BioSciences Inc (DTIL) is a biotechnology company listed on US.
XLI (XLI) common stock.
Latest reported DTIL revenue for 2026-06-30 was $10.8M. Net income was -$51.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. DTIL currently screens at market cap $48.1M.
XLI does not have a complete income-statement cache yet.
DTIL currently screens at market cap $48.1M. XLI currently screens at market cap $0.
Not investment advice. Open the DTIL and XLI stock pages for the full models.
Not investment advice.